Blank-Check NorthStrive to Take Nuclear Startup Nuclea Public at $350M Enterprise Value
NSAI is trading near its 52-week low of $9.82 (0.5% above the low).
Summary
NSAC I signed a definitive business combination agreement with Nuclea Energy, an Ontario-based advanced nuclear technology developer, implying a $350 million enterprise value subject to closing adjustments. Nuclea's flagship is the Morpheus micro modular reactor, a transportable lead-cooled design scalable from 3.5 MWe to 50 MWe, and it is pursuing a pending acquisition of Moltex to build a closed nuclear fuel cycle around the WATSS spent-fuel recycling process. On closing the combined company becomes Nuclea-X Inc. and lists on Nasdaq, led by Nuclea CEO Josef Freundorfer with Sagar Sanghera as executive chairman; holders of at least 66 2/3% of Nuclea shares have signed voting agreements. The deal carries heavy conditions: an effective Form S-4, shareholder approvals, a minimum cash condition, completion of the Moltex acquisition including U.K. National Security and Investment Act clearance, and dissent rights under 5% of Nuclea shares. Closing is targeted for the first half of 2027, well inside NSAC I's August 19, 2027 combination deadline, and the sponsor forfeited 325,607 Class B shares in October after the over-allotment expired. For a $100 million IPO trust trading near its $10 reference, this is the event that defines the vehicle's outcome; watch the Form S-4 filing and the Moltex acquisition deadline of November 30, 2026.
At the time of this announcement, NSAI was trading at $9.87 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $190.7M. The 52-week trading range was $9.82 to $9.95. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.